ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,620Medicare Part D Prescriptions Filled, Including Refills

Rank: 52 out of 337

$519K Total Retail Price of All Prescriptions

Rank: 68 out of 337

309 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 309 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

16% of this provider’s 309 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 10,104 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
WARFARIN SODIUM 597 556 1 11
AMLODIPINE BESYLATE 444 395 2 3
FUROSEMIDE 335 328 3 8
PRAVASTATIN SODIUM 316 244 4 14
ATORVASTATIN CALCIUM 302 289 5 7
LISINOPRIL 298 268 6 2
METOPROLOL TARTRATE 280 255 7 6
OMEPRAZOLE 274 238 8 4
LEVOTHYROXINE SODIUM 273 255 9 5
SIMVASTATIN 236 186 10 1
HYDROCODONE-ACETAMINOPHEN 232 199 S3 11 13
LOSARTAN POTASSIUM 231 223 12 15
DONEPEZIL HCL 207 207 13 22
METFORMIN HCL 204 168 14 12
ATENOLOL 197 182 15 10
SERTRALINE HCL 191 161 16 18
HYDROCHLOROTHIAZIDE 155 133 17 9
TRAZODONE HCL 145 143 18 16
TAMSULOSIN HCL 139 126 19 25
GABAPENTIN 131 117 20 20
NAMENDA 127 127 21 35
RANITIDINE HCL 119 108 22 30
FLUTICASONE PROPIONATE 115 94 23 34
PROAIR HFA 113 65 24 38
CITALOPRAM HBR 113 103 24 17
ENALAPRIL MALEATE 108 84 26 37
AZITHROMYCIN 106 78 27 51
MIRTAZAPINE 106 94 27 27
OXYCODONE HCL 99 35 S2 29 63
ZOLPIDEM TARTRATE 98 80 30 23
ALENDRONATE SODIUM 90 90 31 19
METOPROLOL SUCCINATE 85 82 32 21
DIOVAN 84 84 33 26
ADVAIR DISKUS 84 81 33 44
CYMBALTA 82 68 35 59
METFORMIN HCL ER 78 48 36 52
FAMOTIDINE 74 74 37 115
IPRATROPIUM-ALBUTEROL 74 74 37 96
PANTOPRAZOLE SODIUM 73 61 39 36
LIPITOR 71 69 40 33
MELOXICAM 71 54 40 54
SYNTHROID 70 58 42 41
BISOPROLOL FUMARATE 67 55 43 67
GLIPIZIDE ER 65 65 44 69
PREDNISONE 64 61 45 40
LEVOFLOXACIN 64 58 45 93
DOXAZOSIN MESYLATE 59 54 47 68
GLIPIZIDE 59 58 47 45
VENTOLIN HFA 58 37 49 159
CRESTOR 56 43 50 29
DIGOXIN 56 56 50 58
BACLOFEN 53 27 52 133
GLIPIZIDE XL 53 53 52 123
ESCITALOPRAM OXALATE 52 50 54 66
CIPROFLOXACIN HCL 52 52 54 71
CLOPIDOGREL 51 44 56 42
CELEBREX 50 39 57 116
CARBIDOPA-LEVODOPA 50 50 57 92
ACETAMINOPHEN-CODEINE 50 47 S3 57 142
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.